2,073
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary

, ORCID Icon, , , ORCID Icon &
Pages 653-659 | Received 17 Jul 2019, Accepted 10 Sep 2019, Published online: 18 Sep 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.